Alzheimer's Disease – Framingham SOURCE

Alzheimer’s Association & Health Organization Awarding Framingham Healthy Brain Initiative Grant

Share, email, print, bookmark SOURCE reports.

WASHINGTON DC -The National Association of County and City Health Officials (NACCHO), representing the country’s 3,000 local health departments, and the Alzheimer’s Association and

Business Health

Peer-Reviewed Scientific Publication Demonstrates Central Role of Neurotoxic Soluble Amyloid Oligomers in Driving Alzheimer’s Pathogenesis

June 26, 2021June 27, 2021 editor ALZ-801, Alzheimer's Disease, Alzheon, clinical trial, Framingham Business, Framingham Company

Share, email, print, bookmark SOURCE reports.

In full transparency, the following was submitted to SOURCE media via its business wire service. *** FRAMINGHAM – Alzheon, Inc.,

Obits

John Arthur Surro, 68, Retired President & CEO of Metrowest Community Federal Credit Union

June 5, 2021June 6, 2021 editor Alzheimer's Disease, Framingham South High graduate, John Arthur Surro, MetroWest Community Federal Credit Union, Norton Funeral Home, Obituary, Salem State University graduate

Share, email, print, bookmark SOURCE reports.

FRAMINGHAM – John “Jack” Arthur Surro, 68, of Framingham, passed away peacefully, surrounded by his loving family on Wednesday, June

Government Health State & Federal Government

Senate Passes Bipartisan Improving Hope For Alzheimer’s Act

December 26, 2020December 26, 2020 editor Alzheimer's Disease, and Education) for Alzheimer’s Act, HOPE (Health, HOPE for Alzheimer’s Act, Outcomes, Planning, Sen. Ed Markey

Share, email, print, bookmark SOURCE reports.

The following is a media release from Sen. Ed Markey, who was elected by voters in the Commonwealth of Massachusetts

Business Health

Alzheon Announces Study to Evaluate ALZ-801 Effects on Alzheimer’s Biomarkers

October 28, 2020November 1, 2020 editor Alzheimer's Disease, Alzheon, Framingham Company

Share, email, print, bookmark SOURCE reports.

The following is a press release submitted to SOURCE from its business wire service. *** FRAMINGHAM- Alzheon, Inc., a clinical-stage

Business Health

Framingham Company Awarded $47 Million Grant For Alzheimer’s Treatment

August 21, 2020August 21, 2020 editor Alzheimer's Disease, Alzheon, National Institutes of Health (NIH), U.S. National Institute on Aging

Share, email, print, bookmark SOURCE reports.

The following is a press release *** FRAMINGHAM – Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines